0001140361-22-037226.txt : 20221014 0001140361-22-037226.hdr.sgml : 20221014 20221014160149 ACCESSION NUMBER: 0001140361-22-037226 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220914 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221014 DATE AS OF CHANGE: 20221014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LISATA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 221311331 BUSINESS ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 BUSINESS PHONE: 908-229-2590 MAIL ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 FORMER COMPANY: FORMER CONFORMED NAME: CALADRIUS BIOSCIENCES, INC. DATE OF NAME CHANGE: 20170808 FORMER COMPANY: FORMER CONFORMED NAME: Caladrius Biosciences, Inc. DATE OF NAME CHANGE: 20150608 FORMER COMPANY: FORMER CONFORMED NAME: NeoStem, Inc. DATE OF NAME CHANGE: 20060906 8-K/A 1 brhc10042873_8ka.htm 8-K/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
(Amendment No. 2)

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 14, 2022

LISATA THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Charter)

Delaware
 001-33650 22-2343568
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)

110 Allen Road, Second Floor, Basking Ridge, NJ 07920
(Address of Principal Executive Offices)(Zip Code)

(908) 842-0100
Registrant's Telephone Number

Caladrius Biosciences, Inc.
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
LSTA
The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Explanatory Note

On September 15, 2022, Lisata Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial Form 8-K”) to report the completion of the merger of CS Cedar Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company with and into Cend Therapeutics, Inc. (“Cend”), with Cend continuing as a wholly owned subsidiary of the Company and the surviving corporation of the merger. On October 4, 2022, the Company filed Amendment No. 1 to the Initial Form 8-K to provide certain historical financial information of Cend and unaudited pro forma condensed combined financial information of the Company after giving pro forma effect to the Merger as required by Items 9.01(a) and 9.01(b) of Form 8-K. The Company is filing this Amendment No. 2 to the Initial Form 8-K to file the audited financial statements of Cend as of December 31, 2021 and 2020 and for the years then ended and the consent of Cend’s independent registered public accounting firm as exhibits to the Initial Form 8-K. No other changes have been made to the Initial Form 8-K.

Item 9.01.
Financial Statements and Exhibits.

(a)    Financial Statements

The audited financial statements of Cend as of December 31, 2021 and 2020 and for the years then ended as required by Item 9.01(a) are attached as Exhibit 99.1 and are incorporated herein by reference.

(d)    Exhibits.

Exhibit
Number
Exhibit Description
   
Consent of Withum Smith+Brown, PC, independent registered public accounting firm
   
Audited financial statements of Cend as of December 31, 2021 and 2020 and for the years then ended (incorporated by reference to the Registration Statement on Form S-4 (File No. 333-265638), initially filed on June 15, 2022 by Lisata Therapeutics, Inc. (formerly Caladrius Biosciences, Inc.)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
LISATA THERAPEUTICS, INC.
     
 
By:
/s/ David J. Mazzo, PhD
 
Name:
David J. Mazzo, PhD
 
Title:
Chief Executive Officer

Dated: October 14, 2022


 EX-23.1 2 brhc10042873_ex23-1.htm EXHIBIT 23.1
Exhibit 23.1

 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We consent to the incorporation by reference of our report dated May 20, 2022, relating to the consolidated financial statements of Cend Therapeutics, Inc. appearing in Registration Statement No. 333-265638 on Form S-4, Amendment No. 1, of Lisata Therapeutics, Inc. (formerly Caladrius Biosciences, Inc.), and incorporated by reference in the Registration Statements of Lisata Therapeutics, Inc. (formerly Caladrius Biosciences, Inc.) on Form S-1 (File No 333-239302), on Forms S-3 (File No. 333-196702, File No. 333-206175, File No. 333-210664, File No. 333-214607, File No. 333-220354, File No. 333-226319, File No. 333-248100, File No. 333-252560, and 333-254971) and on Forms S-8 (File No. 333-107438, File No. 333-144265, File No. 333-159282, File No. 333-162733, File No. 333-173854, File No. 333-181365, File No. 333- 184927, File No. 333-191572, File No. 333-205662, File No. 333-212202, File No. 333-215455, File No. 333-218642, File No. 333-222410, File No. 333-225743, File No. 333-225744, File No. 333-248101, and File No. 333-257560).

 /s/ Withum Smith+Brown, PC

San Francisco, California
October 14, 2022


 EX-101.SCH 3 lsta-20220914.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 lsta-20220914_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 lsta-20220914_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information
Sep. 14, 2022
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag false
Document Period End Date Sep. 14, 2022
Entity File Number 001-33650
Entity Registrant Name LISATA THERAPEUTICS, INC.
Entity Central Index Key 0000320017
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 22-2343568
Entity Address, Address Line One 110 Allen Road
Entity Address, Address Line Two Second Floor
Entity Address, City or Town Basking Ridge
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07920
City Area Code 908
Local Phone Number 842-0100
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol LSTA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 7 brhc10042873_8ka_htm.xml IDEA: XBRL DOCUMENT 0000320017 2022-09-14 2022-09-14 8-K/A false 0000320017 NASDAQ 2022-09-14 LISATA THERAPEUTICS, INC. DE 001-33650 22-2343568 110 Allen Road Second Floor Basking Ridge NJ 07920 908 842-0100 false false false false Common Stock, par value $0.001 per share LSTA false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( #> 3E4'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " W@$Y5P7A_E>X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)TD7#Z';B^))07!!\1:2V=U@DX9DI-VW-ZV[740?P&-F_GSS M#4QKHC)#PNY+HE0FOLA>4WEF0X0M?G0 M!P3)^2UX)&TU:9B!55R)K&NM42:AIB&=\=:L^/B9^@5F#6"/'@-E$+4 ULT3 MXVGJ6[@"9AAA\OF[@'8E+M4_L4L'V#DY9;>FQG&LQV;)E1T$O#T]OBSK5BYD MTL%@^96=HE/$+;M,?FWN[G621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M #> 3E7 !-/T<00 $$1 8 >&PO=V]R:W-H965T&UL MC9AA<^(V$(;_BL;M=-J9)+8$(>0*S#@DN:.7RU',]6;:Z0=A"]#$MEQ)A.3? M=V6(35.S)A^";;2O'Z]6[UH,MDH_F;40EKQD:6Z&WMK:XH/OFW@M,FXN5"%R M^&:I=,8MG.J5;PHM>%(&9:G/@J#G9USFWFA07IOJT4!M;"IS,=7$;+*,Z]<; MD:KMT*/>VX697*VMN^"/!@5?B4C8;\54PYE?J20R$[F1*B=:+(=>2#_-9C$6:.B7@^&T98P-A_PWU@JP!9!WC__[(<( M1K?"Z*(Z(3 D)<=]RE=-''C\DJ=&(!R7%F8"BV5*ZF$0&$V9@97J@JI MK9)Z%5H/%=Q7][U,!7G<9 NAFZ!PC2"@YYU.[S) >*XJGJM3>&9B)5UM0\X> M>=:8*%SG81*%\Y#,/]W-PNG=M_ED')V1R>/X F'L5XS]4QC',*.:I^ ,B7@A MG\5K$R6N%,!?!WH%O4*PKBNLZU.P)GFL=*%T:55G)+)0:$1I,E8;X 5LE33F M$Q>_O4,(:5 ;:W *XYR_D$D"^9-+&9>@2/&U2#)VSCK=SF6OCQ$>6#\]A3!, M$K!%<_9V0!Y@'/F:-Z:N19+2@(1I*G(R4SS!*&O_IZA]XY3SK6JDQ"4C$2OP MI?M4*8TQUCV XB[^GG'LSJ 0YVK;W$)QN1MNGF2^(C.9K#!3IG5WH+B]OP>L MELI4JV>9Q\USC6L^_H:AU0V#XC[_'FVJC 6K^5,61]=OBV)P=K&'(R7:L%F_I8Q>/ U?-UN6SVBQ:]5K+:XQGNR/\CFQBS ;)60%SV M**!_L"%V/RY\X:Z>#4G%$H2"BRO0U;O]^N[$JJ+<(R^4A1UW>;@6'-C< /A^ MJ91].W';[NI7D]&_4$L#!!0 ( #> 3E6?H!OPL0( .(, - >&PO M9KEMWDOSAR+DCO9*ZW="C<\W[)&D/ M1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O M:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\" MO @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9 MY=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I:*Q[V_LL) MBS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W M3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y M]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5T MR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00, MX[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/ M+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^ M>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8* \^>Q\ETWLJ.?]74_P$4$L#!!0 ( #> 3E67BKL

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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 23 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://caladrius.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentType, dei:SecurityExchangeName - brhc10042873_8ka.htm 11 brhc10042873_8ka.htm brhc10042873_ex23-1.htm lsta-20220914.xsd lsta-20220914_lab.xml lsta-20220914_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10042873_8ka.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "brhc10042873_8ka.htm" ] }, "labelLink": { "local": [ "lsta-20220914_lab.xml" ] }, "presentationLink": { "local": [ "lsta-20220914_pre.xml" ] }, "schema": { "local": [ "lsta-20220914.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "lsta", "nsuri": "http://caladrius.com/20220914", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc10042873_8ka.htm", "contextRef": "c20220914to20220914", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://caladrius.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc10042873_8ka.htm", "contextRef": "c20220914to20220914", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://caladrius.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001140361-22-037226-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-22-037226-xbrl.zip M4$L#!!0 ( #> 3E4LA:%4PQ, %-Z 4 8G)H8S$P,#0R.#L9C?QU)H2[T-C>\LC>Q(G,[:?Y512^R4% J#% M&HI42,J6\NNW&R0EZK(I^9HDGIHJD\35:/2-!G0PR(<1F0RC..M._#0*#UN# M/!]U.YV[N[LV?FDGZ4U'5U6C$\993F,F6F7]*(R_WE,=BWV:S:I/5NK?&;*V MYGE>1Y;.JF;ANHK0K=;Y[)C'TI*N*JBN:7NM$ MR01;Z C>VS?)[;W]:):BNHJA5?V,,^6&TM&LGX!FO@2F+,"A9X-RL83!:D0H M6*@XSM.-Z/,Z4%I59,DXSM/I^E[+PH6>V3A-1P MN*0:3=%GJQT!4\P:,1I1GH;CK,V2H1Q ]32SK+J9%U$HM([^]1^$' P$Y?() MGO,PC\310:?X6W[\3T4AGT,FXDQPDB==\C%-<$Q^(XH:\M])PL9#$>>$I8+F M4'.T6I M(!J*G!*WAZU>$N:?*?Q^(3]G7FQ1(GRM542#_?4"L'_#PEH3\L'72 MO_P4(H__&'(NXE8%$0^S440!FCB)!30Y""==A%VDQ:.L+1^APCG@/0T9B>D0 MFXJP6ZU%@0X_"-W1*5=UDOF9JU/4"Q]&Y:WK,#"C7[1)SD_Q*!(IKE M"L,2@:N9GO8P(*00AXP!B2J.SF(O) MSV):@]0RA>EJ/J.F;YH6,SU;Z)[KTL#059>9?@.4(4$8J-B :BS M2%RI" 2*8I$=':#V[F92+T.W1&KS[B#%$5 @*57?[4G&6V4Q"K##5A8.1Q&L MS$%GL8]BN/H8\C5+QJE\D]9*MYR*G/W:J93UA%S)ZBWD^!Z$(B5R/+%6Q_;. M?EY#;$3C7:59RX4"@#I P3.9RM12>]\C5 M!:$,RBH7Z0D)Z5\?7Y_VOQVP M^J>]7Z[.KL].^^3X_(2<_M;[\?C\AU/2N_CRY:S?/[LX?W%8]4VP_DJS 5@M M>1+ODY-VKPTVB&5Z]\&W/5<=^.F,WJ"OEYZ[NVGNGRZNOI %HD??1 DG2J$1 MNLUL"#01'L<:,R-J:[MLW;3V9D8(.4]@0=]_@ZOYM#,&=KLZ/;\F5Z>7%U?7 MWP1(E^,T&U-8@CPA8-R@&TLT@R0IT:P]_IXD M8?Z=5JYUA,H>9W8E1DF:D[WJ75!0]R++B;A%HDUEL>#ON^1!>_]2F@RGA2%1 M,QBYYX*1J.G O-04MNZK7*6FI0I5M0W']K:TMSGTK@RAQ0!!4#B=*E. 6@$' MYJ@O1KD8^F!W:>:^=.%6C8; M7!BFZ;FVIPO'L (5W W5\SVC@6W_^:Q_?'U,KG\\O3J^//WE^JS7WR=GY[WV MRDJ\,@?LG4Y@R@0Q4#!"A1-",](?"88V."=A3'H#,*-%^K*R.Z=^)&"Z403: MC(%9<-A26_)]1#FOW@MC5C[N&DZX"WD^P!?UOV?&,6 WHJ,,ZE1/#<(.K:-Y M/*4669'/!WEZ5/]6U3C(>05X"8>AMST/(+D5:1XR&E5#%O;\#AIA#?4\R"!G M,4M2D'PRY-G/0>+TBD!B+^%U?F'4H$QU#5?GCAE8E%)/Z!A88."J.WZPG6A# MBP=]MER,TN0684*9=B(B>D?3U:C" OU45)3SIG@VVZJV!L]#,+0:G.AN8%F^X8M3,ITU^">)9CC,*;YAM4DP #^M&(8MJ6NBO_F"#)> MFPJOZ>2L# 8P28DKJ'(#1[5U6U,!.::PF"M,W;.H;[IF8-M!@U#6D:XK.A"L M9;L[$9AD[LX2=[\NQ[>6QMU-$8."D(R/9N(%F([E,RUY/-]>RJ3TZ'HRB9PG(OLAZZ;\TF MO88CJB?6? MS]!&JRL[+U!]US:8\'53TSGEU.*ZX[) -2Q#-%!V1YJFDN,H$C&L)>7+ F=_ MLX^Q"3Z];KRZC.F^16W7,4WJ^I[&##4P02DS+DRUB?$*+F 2<_(I2I)T5^AZ M\'B17B=W<3V2+RS*'->GO@8ZS;%]QU-U6S.++4!;!]I]A7WM*YP.VI7 MX*1(NT@OP;X(Y=;V#$*=44$MUZ.:YYD>,USJVK9JV=0!;6)YM$E8_Z=EL!I" M=9F U1/]7SA:,J]LSW$YXX;JV]P48&OYC%'-U T?PSY>$XI3'4]?8P6\2H0( MPT'%A%%]7*:P N&(1N1T(M@X#V\%N0A WHCL_1[@@B R_E;QHFTDU=Y&RD'^ M.DX%7:(5W0834=4TF_G49*;J!LSG+C,#YOC"LYO0BJ>NV$#O-U/PYP14U^4@ MB5E%HW](K2T-?2$ 65F19K*9T#G-0Z]:NLOO\_YPH9J6[G(/G/F NFK@ M>9YCJAJEKML@[K$23/*3)/(ID%D.5-\Z^N[=!(,%'QI$179 2+'#_;!SM@7S M;Q4:;QV5&(;6=12346W_YVH,Y&OJ5LF72_L^N-VSISFD]^F*Z(;:AHIKG;Z* MG]:B;6U(9)525YW!HL]%'EW#M6]<_)ILNEPQP-+U%$%Y1;U'-42;RS\$ O/T4N&)7Y7^5V*^=,;"I MMHN:;SS\QL-U'KY,!6IAM-9EHBK:>BGXW@M.'/=L7V,F9Q:S34U3J:IZKM!\ ME5DN-XPMTT3_B;P,:%98#<\/ZF7-Y(J^Y[]OQME%W3?>?N/M>WC[+,O&(EW/ MX:IJ,Y4;W/"I, U'H[IEF\QA7.C4UZG^QN%/S^&&4,P]UHS#R[I_"0Y_01]] MET5<&+'F\!2!"I$*OK!6LRPY*8W+H :LSVIX8AVX&W.7UTV85*G,;RDPL\U1 MYY[-T1*\(JES1V_U.NP&FJT7!HQ?E)]E-MYA]G367I_'( M57E&5%;YA9)F1:7K0+;>#4+X,A? NR87O+QT:4C"KY7&\>#!-DWWI2BI'T[4 M5-^R7<=U71U,0,VW M_W7&9YW/,LO\E).[0Z85G[><*^[I,13[(<&L%F[0=_]8K7,JM0FS54T,T<-P#55"-FI@;YSMZ MX#FF[IFV)@R[R=G3S_WKU:.GS[%T&V3EUHM7GC'[JR[Q0T>!'CR&>G0--NLY MS3C]@_3H*,QI1+[0]*O(JZW9W5=OC1BNGIXVQ^NIMD+/8HY.F2#^E#"Y+3H$ M5( .$C*U<6G/,LP((!\\.CRL>$-NTN0N'Z!O-\)]3)H1+H(P+I+CBPT5U5IS MBF9^>,8@>]^]TVSG@]Q4J2J'V1Q]H!='F&./.]:%IZC[BM[P:,ZL=_0:Y^U@ M&E6W[9=&.-G-"=H.S,73I##W4;YTZK3\]NAS>P\$78ILKM.28'Z0]-(KR&4A MWB*$[7 UX+9KNJ[C6;KK"CB^1%@9K?YX=?GIDMZ(CZF@7S$;B^FH->Z8W0ZP;+-L M'&0VP B^*#Y^4FB0(VII=$>GV9+I4UN"8LP"VQ)UZ^)-Y3=UCF:]CN5[KG:I MBNHS1[QM$[9\L;.XIY-11&.:)^F4G">Y^':$Z>-EY 5X?_,#J%9Q '6?? XS MFE,"YFA*1V(,5GV9(DCV4%9\]\X%[;9&LBX?K%Y00K*5]N$]YJ"!1**D)^^M MRJL#O7A"#RBEQ!*>BD3!7UU#>4]3!]>.OU24^ MY"1?BD_]L5_,>Q_ K4ZUD=H9&A#).).[01)%4Y+8+48U;$4^^L6.K%&P4T7!"LM+QN^+U46#4K&YQ*"D8[F,; M@>A>UG1>&,]N>9/+A]-&^,7,D%%.!+7V!C1POX0(E) M;@I4S+L300!JM)I*22\4MR?^&(>X.0$&PADP5D:\MJJAHD7 Y'.Q/U'-NHTT M,!L-'( B17.. >D5+%W*)6:?$!;!'O$4^L9/H&%),V6BE@ N1D"5_:*Y*@Y'S KE8L15I4'\VL; M-WX$UGC-9 E"F #:29-!Z(< 7S'!.1:69]H&1)!$NH*%X9*!G74+=ID X(:4 MBTTHVLZO:MV_-?2@R%W9;9FY38^[:JBI,]9L0VKMAOK3[$V]T :4;>#(:R-0 M3V($("M+[FUO$1P\-]0&52C 4((>9U<$WJOK_FJ^RAY?8H<5L?4BL_RGIGBXF_=@GW(O M^O'>NB2*]0E8KP?6XJ'#!9B:VQ.>_LU=07#?&H" S%@:CM"K>JE4@754NNO] M,!A"1D'SV!5Z\O&?"4^[6H^3A7G MJVY[D#'T>R?_7!^?/W+ M5?-;S]^B1P^#4;^SNF9AND!6VOYS6AJDC? R"A-&Q_#49W NJ-C,3 MX@N2P1P* 86[)KX8T"A Z;2P>2*/+I4U,4PTQOU'V2\=YX,DA6GP)XZB5)KB M+7HBX3"]MKTQ1_8Y+>.G&1"1@DQUV-*?QL&YY\[EE_%4-BW("WHKKSR\:;X0 M!IYQM9Z=?>Y9JE<,#WR<=A_I'6U:_'K._NLEVM\W]T[6(2?T%J#YJ4V^T#__ M3/;)Y>#DM>7&/Y02\:S8L]+BZTSKC<"^E960Q]Z>B\*>?^_DWB#O(!3!RE6J MS3:)=@X(O'EUV__J#._.LASG/]+R.AOKWU;?M=691UIV#9VL"W\L'@5HGH"_ M.,V%W^-[]M_\.^C@;Z4>R9]/S8<1//P_4$L#!!0 ( #> 3E6A_\P^F , M /0+ 7 8G)H8S$P,#0R.#4YA](51XG:II=O?@$8)91$14NW%5,IO1SURV<%_FH8<,M"RC,:@1(#N)*" M1))%&UI&%->U"/=;RA6$DA*E(_<9XYM:+-PMYC%+*6#<0V8/]1S3-VL)QF)W MD&R3*$!!X( !V,2X/M\P2L+]BO%H+:(#K#>A2(6\Z)S%Q=6!3!U2>M&)!5=& M3+8L/0S@[8IM:08S>@\+L27\[1"*\8S]30> S)T:@J(/RB IV_ !I#362)%Y M &=F<0T[Y?H1^^MH32*AF'#1T?8H*CO 19:02"]?-1[I)#37-@![]]!*#&L2 M_KF18L\CHSE49U4N,H0MD1O&C9SD ,A>B4=(EHN4V%K(B.I<7'!:D7]&O]$I MNT>^]76+K&W6KW:X .XK(]8BC32KR4/"UDP!MGIHU']&KO\"UC3X7U$ZGL^6D]D*YC"CD3DBBF."P/H"D,964AQ1$#&(O-:"'%41%R?A(#OJK[Q9??EKB%5 MLCRW2%D9&C-.>,A(JC5I(*\\69YS3'E4*RJP2J@D.[I7+,RZ,.5A#\AN1XG, M$S,."[IAF:H(+H^I8"9Z8%F6@5W'M7S08S=";F%IV%UXKR.BQRC4S9>]91E1 MY-1J[V(]D86G&:;/3%X M0?K7D:G)1?#N)J_9,U':8066B37;*B+3(=9C2&D9"ES/U-OW#,2FBSRG"2+3 M=>T6:+NFUP2Q:3FM2.Q:*'@"Z]J+<=M'IMF.B\Z-=$^4U1 MIF=;?B,7LFW]?C1!)\!^4SYRL6=93="S_)8HY".KE1.0;P>X:0H*D./A+^@W M'==M;0327K9!QW;:N^.[=BL28QNU/,6.=N<4V-JR?$M0Z7YC6SR]+>>]'_\' M.%7S3O[=OZ'@E96VG_7A,U/)7G\P6_W\79]9[GD7[L;_+S5+HM]_F5?5+!3= MO$(P72XX(S^;R#Q48DTE(+O\%;QH8]VWUP_7A'W#>0[_9^>YNI2G]K$UZN?' MXZ)1G?7_ 5!+ P04 " W@$Y5">\JPT4# ]#P $0 &QS=&$M,C R M,C Y,30N>'-DM5==;]L@%'V?M/_ _(X_DG9JHJ;5IK93I6Z=NDW:VT0P3M P M]@ WR;\?8./83I/&\?;&QSGG'BX7C"^OURD#ST1(FO&9%_FA!PC'64SY8N85 M$B*)*?6NK]Z^N7P'X2?"B4"*Q&"^ 1]%AF)!XP4!7Y\>$\H(&(W\*/0C_SR\ M"!OS$!K^6DXE7I(4 87$@J@O*"4R1YC,O*52^30(,&*&44@?9VDP"D>C,I(2KNTRD-R1!!5,S[T^!&$THB3V@E\#E="UKG=5JY:_&?B866B2,@I^? M'[[9R [+I$*O1JV@E/]N":_G@CGI<6"FYTB2VL4.OC(232:3P,[64"U$#TA3 MKEUR3)KX6-6$)O@\*"<=5&^70NW#UU,M0DQHVX: .5Z"BWUJFG S-M."$,(SB*/%TJ )AB09QG"BE=F':H&LQSRI.L M&M%C)J-3MPM/) $VQU.C.O,D37-F$FC'EH(D,\_L/72[_"L7Q-=6'41DC!S8 M$C,=:(K4U6B=/6P#.PDD\([*3@UHD2PG0E&=V&T)!?]L60S-^RY+4PC[O^LQ M.M_U"H!I_'BZWW,$K9V;#!?FT'_@\2U75&WN];:+U&;= S2>>0<1=607.R8) MY=164ZCOA# $$#B%9A/Q&)1RH*%W&71%NOJ%)/$CO[+M;H54[ IRB*D3@0MV M G'K;#^O&G6[X$Y5T#E6Y4#[\)FCIXLN$PKPG6N[>;DL$,JK&Z"\[!\R;&5* MM'07QHN<@# EW8@M9G\M8U='!SWLN84.>NC"36- 5)P57(E-G\A-BNL,<5 ( MH;_>_2PT.75O@ FRQLL^!FJ\;0T(S!'%LD_D+:%L#H@M*>X3V<%-HU_4[N4] M*6]+3A;F6?9R^"Z-"=%B0:,#HQ&,W@_WH7I[4*?$;Z=3Y:)7^AW>MH9M0/.= M=LS"+<7TH..9Y8_-\L?1R2[. F&^V$<:L&@3]@R&%U"_V'ME?>?->6141S"! MSX\.N>_E.N#K8F6&'KOJ6:3]807).F>((Y6)S9WN'W\$FBJW6Y%33D3SR=XK M1PY?YL<\^'NE9N^OPJG1AV[/2S\5>\V\QK1]N35B'T>EV-5?4$L#!!0 ( M #> 3E7'*RTR@ @ '58 5 ;'-T82TR,#(R,#DQ-%]L86(N>&ULS9Q= M;]LV%(;O!^P_<-[-!M1V+&/#$C0NLBPM@J5)D*38%X9"EFE'F"P&E-PX_WZD M)-HB>4@I%27KIG5XWO/RZSF2K$1Z^VZ[CM 73).0Q*>#R>AH@' ('F+^A72OP%#1+_?[J[-&8?C[EB'./TRI_CB'69I:* ME[!/1.G.AJ_.,5^=R<]\=;[?.X^;#&_%:7H@J1^Y&6?FIX]5ZZ;YH*]=+:UM MR-Y@E4O=-!_T+:8A65S$B_8'KG;E:O#WJ4\[0$7OK/D$VA\U,-2( M-UVQ3U*_>)OB>($7HF?N;3EV9EUG!]O,>>=- LDUXF<10O7I),PU?/LWF24C](A5,VB=,!&$O#E(]=B8WE@?)\ M::@4)V1# ZSTH(W@*,Q8=!28!R!>KABK-MCK1LMTU ]AA[:KZ$SUON"C^!]Y*\44,%8,5TEUJ 4 M)"=7W$.F)LAU[6S7A'C;8=F%=X%4+)Y,I203" *YW=V(>!\F@1_]A7WZGK6H MWQ(K5,KM"4WEX$Z%XNGZI@5L7W7_ LK:W\K(HXB'41;OQWT-TQZ2V@L.W^U0 M$M0;'Z!?UWSG=]BK"0=T(..2SAGE)==V.-<[J$>ZFJ>QG@OZ1SNTGR#OAJ6W M$5]*@9G7/+NC?O<+L=_8=V$#\:!&H5W1."!=1;B>LZ>[P)H%$8_V M@VQXWTC-98:)EN0JS8!7^R1?Q&RD+W=X%?)?T,3IM;]6L;))BFG"D@880X:N M*+9XFR VILSR"-J'$(\=EF#KAI%Z"RSS"ZD%OF:GKN@]9\5#_>B2?9G<_HY? M0'P-&HE?3=,88,71+<&PN1UA*$*3?M&:BXSQ+$BET$&O;HB M^7T8X>O->J[=RS.%)7[+X<;H[LW<4JOYVH%5Y()5WHSR]CY0"FP,J5Y,B,V] M4L92=>B*R =_>[E@)1$NB]]*6O"LT$JL&K6-P34XNZ78WHD=:5NNX)MID"SJ M$>U5^TQ>N1U0'1C2Y**P>G=5(9=Q0.@3H=D [E-V[7Y.-NP<\G).%O"E=*T, MJ5HJ,AK7C-7?;>74Z/]4.HHHDY1N4:1&AJ- CGM"'@JH'!/FJ'8.*RYHL MEUB-?KHJM(LUIJLP7GV@Y#E]/"?K)S^&+_:M2JFP#,K&!07ZNBTD6Q?V C)G MBL(1"I1+4*'I0ZW8]Y:\:A.@V@"3Y)JP^'95"V>+!6,P*?Z["F,\ 2O!HI/J M -0UK@+ U6T-F#NP5X I3_!?!-Z(#XA+T$WAZ. M?*\F^5Y-\KU6R/?:)M_[2O*]&N0_/)-^DN_5)=][/?E>%?G>HD0[L(L0YO.06RO<)(..J7\>$9U^Q M;^@M)5_"6 .NCA1B79.Z EXQ;H5ZN(]:Z$.I&O^[VT)"UJ,B,.TQ5 F6O;"4 M@Y(%U@3HW/6A/[_M9#WNRQ+PH"\DSH[XN6$[AWO)N]ZQOI2B'^CS8(_P5G<, M/,#K*VP[NA>W=L%#>]FI8WQO29+ZT=_AD_&W C8AA+(B= 6T9-L*UE /M>#6 M$S7$BA4#%!.=3DK0\E M(V]\4*6S[%*;-_6 3G #B'WA9 ++JMW;'K3,]BGC+[J*;A])#/_M MC"E<3$8/-R!.-7-%G<'71!XHGV6M*&ONQ5\3&#>&5"^F3**J%#3"#AT\48^# M#665,/'F#WR@"BFF<#$I/=SD67K%S-F3]+"O\3EZ2#[+/B*R1!/OA_F/2(@. M_"2]:7=(]8K*6*K*W3/TH$/[6%Z3!^KS%Q?>OZSG) (>@;0HBJF!B@9\ GZN M$#5;FR@U9J W.Y.W1?;X)%M!@8>B+%)E%.X M+'%P&B\;NCZ5 ]Y5IW,M928B2(1Z\$",=<-(O06&S^QEM7IVUYV*=SB6UN** M?>)O_BV:POQ-N;/_ 5!+ P04 " W@$Y50S@Z5=T% #T/@ %0 &QS M=&$M,C R,C Y,31?<')E+GAM;-5;76_B.!1]7VG_0Y9]AO Q,SM4948LTX[0 M,"TJK/;C9642 ]8F,7)"@7^_=K!;XMA.Z,?H]J6%W./K>WQ.8G()EY_W<>3= M8Y82F@P:G5:[X>$DH"%)5H/&-FVB-""D\?G3SS]=_M)L?L4)9BC#H;+\S MBD)&PA7VIG>W2Q)AK]MM==JM3NM]^V/[)-YLBO$12?Z[$'\6*,4>GS=)+_8I M&3366;:Y\/W=;M?:]5J4K?QNN]WQ__H^F05K'*,F2=(,)0%N>!Q_D>8')S1 M65[TR?#]@D4J0<]_F,N*$.^:"M84AYJ=;K/7:>W3L"%+%.$:DRCXOH27G#K] M?M_/HP]0GH@X4C_0YJOG>!-A=6S-\-*<)V+L(8U8G;Y8G2KAI3C,4O4R= M>;YRK:5IGE_TS4LMK:ODFY=<97Z6XQ^PRB?3/+_H*6:$AE=)^/J%ZU.]5/&S M#+$?8)7R9,\G\/I5GU%J@"*QGVS35D#C8^XO--C&.,F&"=>5G=;KO?>9<7YJEFG.,VIUFD*RS&*H6.6IBD-6K!BQ0&7B+PL2 MEK=JB? WB/%\S6!-H@?UEXS&MI6DSM)/R[OP"AF\C'K%D92%F T:;?$1C@]< M8L;DZ>6H.R\Z.CT'7U/ (:\V%!5?1VBE*6B,R7708O T=!5?(:(V5*K8 :RB MLMW#?OF%7\@MYZ,1HYV8&@:>NG7(U#Q5M112[>X;4/N:I'SG^ALC=LV/I!:] M+2A-\1(*KN9N0C55+R61NO?>C.Y'WU8K;\ 9M2_@H*MO)W66_H4TT@'O #O@ M^%'TFD3X9ALO,-.$MX7ETI3#\&2NH%"A;GFT%/4]>%'O\(H((DEV@V)][W9! M"N+J$*@".ZG4$EG/((7^ %[H$:?&4#3F=Z/[;_A@5-J"*4A=PD#5VDVFEMBE M%%+MW\"K/4X"RC:4Y?QFG"8>T2TG M^0C>,W.T'X><+5F2XQT<,Y0R M*4? [P0J.Q]O!%0$.#*FZF<=?JK#$II^.U!6?F4IAF*_B$;:_O M!32IK@&!:^^B=8X#M#S*!Y"[AV+/&C*,#,J;0NJ)D$((GKJ.TBOT+(Y4"D+N M"(KG8Z/IFB;F;V]L8;D ME('<-[NAA:(-#[DY$')5C AXPE83J9#7F$")#+DSIJXP5_M@C9(5-GR![H)H M5^(B!)[.-:C4O"(7,RBEX3? KF+,5MRG7QG=9>L1C3)O);/?U1."=&KI,% T_Z.F0J1+>D4')# M[GC-:$0"DG&O?D<99@3I'\OL '6%-P#@J5Q)H^KJ;ABO](77=NF7EG#"#X@?GA\CXH_XH?:G_P%02P$"% ,4 M" W@$Y5+(6A5,,3 !3>@ % @ $ 8G)H8S$P,#0R M.#\JPT4# ]#P $0 @ '"%P ;'-T82TR,#(R M,#DQ-"YX&UL4$L! A0#% @ -X!. M54,X.E7=!0 ]#X !4 ( !Z2, &QS=&$M,C R,C Y,31? =<')E+GAM;%!+!08 !0 % $P! #Y*0 ! end